Popular Articles

Innovative Technology Shatters The Barriers Of Modern Light Microscopy
Researchers at the Helmholtz Zentrum MÃønchen and the Technische Universität MÃønchen are using a combination of light and ultrasound to visualize fluorescent proteins that are seated several centimeters deep into living tissue. In the past, even modern technologies have failed to produce high-resolution fluorescence images from this depth because of the strong scattering of light. In the Nature Photonics journal, the Munich researchers describe how they can reveal genetic expression within live fly larvae and fish by "listening to light". In the future this technology may facilitate the examination of tumors or coronary vessels in humans.
pharmacy online
Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities
Over 100 certified breastfeeding peer counselors, lactation consultants, nurses, physicians, dietitians and community health workers are expected to gather at Rush University Medical Center on Thursday, August 6 from 8 a.m. until 1 p.m. in Room 500 at 1725 W. Harrison Street, Chicago, to attend the Griffin Inaugural Conference on Breastfeeding: The Primary Foundation for Health.
News of the day
Cigarette Smoking Does Not Affect Everyone In Same Way
Cigarette smoking induced COPD, or chronic obstructive pulmonary disease, is a disease that results in severe breathing difficulty. According to World Health Organization (WHO) it is the fourth leading killer worldwide. However the mechanisms responsible for some smokers developing COPD and others evading the disease have not been well understood.
Health Insurance

Hospital Trust Recruiting For Trials Of New Flu Vaccine, UK

Southampton"s university hospitals are to take part in clinical trials of a vaccine that could protect against numerous types of flu - including pandemics such as bird and swine flu. Existing vaccines target only the outside of the flu virus, which frequently changes and varies in different strains of the virus, meaning new vaccines are needed each year. Novel new T-cell vaccines target the internal core of the flu viruses, which do not change very much over time or between strains. The study is being conducted by research staff and clinicians based at the Wellcome Trust Clinical Research Facility (WTCRF) at Southampton General Hospital and the Jenner Institute at Oxford University. "The current approach to tackling flu via the coat of the virus is not adequate because strains are constantly changing, new formulas have to be developed at short notice and then people are only protected for that particular strain," said Dr Saul Faust, director of the WTCRF in Southampton. "If successful, this new type of vaccine that targets the inside of the virus, as opposed to the shell, could potentially offer protection against many different strains of influenza A, including those that cause pandemics." Dr Faust, a specialist in infectious diseases, added: "Such an advanced vaccine would be suitable for all ages at any time of year and, as the substance of the vaccination would not change from year to year, there would be no need for annual injections." Three hundred healthy volunteers aged between 18 and 45 are required to take part. Initially, volunteers will have a blood test to see if they are immune to a particular strain of flu and 26 people who do not have this immunity will then go ahead to trial the new vaccine in the second part of the study. Southampton University Hospitals NHS Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):